2004D-0035 - Draft Guidance for Industry on the Preclinical and Clinical Evaluation of Agents Used in the Prevention or Treatment of Postmenopausal Osteoporosis; Availability 

  


  

  


  

  


  

  


  

  
FDA Comment Number : 
  

  
EC4
  



  

  

  



  

  
Submitter : 
  

  
Dr. Gary Galletta
  

  
Date & Time: 
  

  
04/13/2004 12:04:47
  



  

  
Organization : 
  

  
Procter and Gamble Pharmaceuticals
  



  

  
Drug Industry
  


  

  
Category : 
  


  

  
Issue Areas/Comments 
  


  

  



  

  
GENERAL
  


  

  



  

  
GENERAL
  


  

  



  

  
Please see the 8 page PDF document attached with comments on the 1994 Draft Osteoporosis Guidance.